Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 8-9, Août–Septembre 2012
Page(s) 757 - 763
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012288018
Publié en ligne 22 août 2012
  1. Salomon B. Les lymphocytes T régulateurs CD4+CD25+ : vers une immuno-modulation thérapeutique ?. Med Sci (Paris) 2002 ; 18 : 1066–1068. [CrossRef] [EDP Sciences]
  2. Joffre O, Santolaria T, van Meerwijk JP. Utilisation des lymphocytes T régulateurs en transplantation : supprimer l’immunosuppression. Med Sci (Paris) 2008 ; 24 : 689–691. [CrossRef] [EDP Sciences] [PubMed]
  3. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007 ; 7 : 585–598. [CrossRef] [PubMed]
  4. Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006 ; 212 : 217–237. [CrossRef] [PubMed]
  5. Tarbell KV, Petit L, Zuo X, et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 2007 ; 204 : 191–201. [CrossRef] [PubMed]
  6. Miyara M, Amoura Z, Parizot C, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005 ; 175 : 8392–8400. [PubMed]
  7. Scalapino KJ, Tang Q, Bluestone JA, et al. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 2006 ; 177 : 1451–1459. [PubMed]
  8. Uhlig HH, Coombes J, Mottet C, et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 2006 ; 177 : 5852–5860. [PubMed]
  9. Morgan ME, Flierman R, van Duivenvoorde LM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005 ; 52 : 2212–2221. [CrossRef] [PubMed]
  10. Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 2004 ; 16 : 249–256. [CrossRef] [PubMed]
  11. Masteller EL, Warner MR, Tang Q, et al. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005 ; 175 : 3053–3059. [PubMed]
  12. Godfrey WR, Ge YG, Spoden DJ, et al. In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004 ; 104 : 453–461. [CrossRef] [PubMed]
  13. Levings MK, Sangregorio R, Sartirana C, et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002 ; 196 : 1335–1346. [CrossRef] [PubMed]
  14. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004 ; 199 : 1455–1465. [CrossRef] [PubMed]
  15. Fisson S, Djelti F, Trenado A, et al. Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire. Eur J Immunol 2006 ; 36 : 817–827. [CrossRef] [PubMed]
  16. Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 2003 ; 102 : 2180–2186. [CrossRef] [PubMed]
  17. Battaglia M, Stabilini A, Migliavacca B, et al. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006 ; 177 : 8338–8347. [PubMed]
  18. Tilg H, van Montfrans C, van den Ende A, et al. Treatment of Crohn’s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 2002 ; 50 : 191–195. [CrossRef] [PubMed]
  19. Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002 ; 195 : 603–616. [CrossRef] [PubMed]
  20. Groux H, O’Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 ; 389 : 737–742. [CrossRef] [PubMed]
  21. Wakkach A, Fournier N, Brun V, et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003 ; 18 : 605–617. [CrossRef] [PubMed]
  22. Bacchetta R, Gregori S, Serafini G, et al. Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. Haematologica 2010 ; 95 : 2134–2143. [CrossRef] [PubMed]
  23. Brun V, Bastian H, Neveu V, Foussat A. Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int Immunopharmacol 2009 ; 9 : 609–613. [CrossRef] [PubMed]
  24. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009 ; 30 : 646–655. [CrossRef] [PubMed]
  25. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 2009 ; 106 : 1903–1908. [CrossRef]
  26. Kim HP, Leonard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007 ; 204 : 1543–1551. [PubMed]
  27. Tao R, de Zoeten EF, Ozkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007 ; 13 : 1299–1307. [CrossRef] [PubMed]
  28. Mekala DJ, Geiger TL. Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Blood 2005 ; 105 : 2090–2092. [CrossRef] [PubMed]
  29. Urnov FD, Miller JC, Lee YL, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005 ; 435 : 646–651. [CrossRef] [PubMed]
  30. Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 ; 12 : 431–440. [CrossRef] [PubMed]
  31. Siri A, de Boysson H, Boursier G. Actualité sur les lymphocytes T régulateurs CD4+. Med Sci (Paris) 2012 ; 646–651. [CrossRef] [EDP Sciences] [PubMed]
  32. Mirabel M, Ferreira B, Sidi D, et al. Rhumatisme articulaire aigu : perspectives. Med Sci (Paris) 2012 ; 28 : 633–638. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.